9HTS
Human KHNYN KH domain
9HTS の概要
| エントリーDOI | 10.2210/pdb9hts/pdb |
| 分子名称 | Protein KHNYN (2 entities in total) |
| 機能のキーワード | zap associated protein, antiviral protein |
| 由来する生物種 | Homo sapiens (human) |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 42241.69 |
| 構造登録者 | Youle, R.L.,Cottee, M.A.,Taylor, I.A.,Morris, E.R. (登録日: 2024-12-19, 公開日: 2025-02-26, 最終更新日: 2025-08-06) |
| 主引用文献 | Youle, R.L.,Lista, M.J.,Bouton, C.,Kunzelmann, S.,Wilson, H.,Cottee, M.A.,Purkiss, A.G.,Morris, E.R.,Neil, S.J.D.,Taylor, I.A.,Swanson, C.M. Structural and functional characterization of the extended-diKH domain from the antiviral endoribonuclease KHNYN. J.Biol.Chem., 301:108336-108336, 2025 Cited by PubMed Abstract: Zinc finger antiviral protein (ZAP) binds CpG dinucleotides in viral RNA and targets them for decay. ZAP interacts with several cofactors to form the ZAP antiviral system, including KHNYN, a multidomain endoribonuclease required for ZAP-mediated RNA decay. However, it is unclear how the individual domains in KHNYN contribute to its activity. Here, we demonstrate that the KHNYN amino-terminal extended-diKH (ex-diKH) domain is required for antiviral activity and present its crystal structure. The structure belongs to a rare group of KH-containing domains, characterized by a noncanonical arrangement between two type 1 KH modules, with an additional helical bundle. N4BP1 is a KHNYN paralog with an ex-diKH domain that functionally complements the KHNYN ex-diKH domain. Interestingly, the ex-diKH domain structure is present in N4BP1-like proteins in lancelets, which are basal chordates, indicating that it is evolutionarily ancient. While many KH domains demonstrate RNA binding activity, biolayer interferometry and electrophoretic mobility shift assays indicate that the KHNYN ex-diKH domain does not bind RNA. Furthermore, residues required for canonical KH domains to bind RNA are not required for KHNYN antiviral activity. By contrast, an inter-KH domain cleft in KHNYN is a potential protein-protein interaction site, and mutations that eliminate arginine salt bridges at the edge of this cleft decrease KHNYN antiviral activity. This suggests that this domain could be a binding site for an unknown KHNYN cofactor. PubMed: 39984050DOI: 10.1016/j.jbc.2025.108336 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.198 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






